Gao Ning, Chang Audrey N, He Weiqi, Chen Cai-Ping, Qiao Yan-Ning, Zhu Minsheng, Kamm Kristine E, Stull James T
Department of Physiology, University of Texas Southwestern Medical Centre, Dallas, TX, USA.
Model Animal Research Centre and MOE Key Laboratory of Model Animal for Disease Study, Nanjing University, Nanjing, China.
J Physiol. 2016 Jun 15;594(12):3209-25. doi: 10.1113/JP271703. Epub 2016 Mar 4.
The extent of myosin regulatory light chain phosphorylation (RLC) necessary for smooth muscle contraction depends on the respective activities of Ca(2+) /calmodulin-dependent myosin light chain kinase and myosin light chain phosphatase (MLCP), which contains a regulatory subunit MYPT1 bound to the phosphatase catalytic subunit and myosin. MYPT1 showed significant constitutive T696 and T853 phosphorylation, which is predicted to inhibit MLCP activity in isolated ileal smooth muscle tissues, with additional phosphorylation upon pharmacological treatment with the muscarinic agonist carbachol. Electrical field stimulation (EFS), which releases ACh from nerves, increased force and RLC phosphorylation but not MYPT1 T696 or T853 phosphorylation. The conditional knockout of MYPT1 or the knockin mutation T853A in mice had no effect on the frequency-maximal force responses to EFS in isolated ileal tissues. Physiological RLC phosphorylation and force development in ileal smooth muscle depend on myosin light chain kinase and MLCP activities without changes in constitutive MYPT1 phosphorylation.
Smooth muscle contraction initiated by myosin regulatory light chain (RLC) phosphorylation is dependent on the relative activities of Ca(2+) /calmodulin-dependent myosin light chain kinase (MLCK) and myosin light chain phosphatase (MLCP). We have investigated the physiological role of the MLCP regulatory subunit MYPT1 in ileal smooth muscle in adult mice with (1) smooth muscle-specific deletion of MYPT1; (2) non-phosphorylatable MYPT1 containing a T853A knockin mutation; and (3) measurements of force and protein phosphorylation responses to cholinergic neurostimulation initiated by electric field stimulation. Isolated MYPT1-deficient tissues from MYPT1(SM-/-) mice contracted and relaxed rapidly with moderate differences in sustained responses to KCl and carbachol treatments and washouts, respectively. Similarly, measurements of regulatory proteins responsible for RLC phosphorylation during contractions also revealed moderate changes. There were no differences in contractile or RLC phosphorylation responses to carbachol between tissues from normal mice vs. MYPT1 T853A knockin mice. Quantitatively, there was substantial MYPT1 T696 and T853 phosphorylation in wild-type tissues under resting conditions, predicting a high extent of MLCP phosphatase inhibition. Reduced PP1cδ activity in MYPT1-deficient tissues may be similar to attenuated MLCP activity in wild-type tissues resulting from constitutively phosphorylated MYPT1. Electric field stimulation increased RLC phosphorylation and force development in tissues from wild-type mice without an increase in MYPT1 phosphorylation. Thus, physiological RLC phosphorylation and force development in ileal smooth muscle appear to be dependent on MLCK and MLCP activities without changes in constitutive MYPT1 phosphorylation.
平滑肌收缩所需的肌球蛋白调节轻链磷酸化(RLC)程度取决于钙/钙调蛋白依赖性肌球蛋白轻链激酶和肌球蛋白轻链磷酸酶(MLCP)的各自活性,MLCP包含与磷酸酶催化亚基和肌球蛋白结合的调节亚基MYPT1。MYPT1显示出显著的组成型T696和T853磷酸化,预计这会抑制离体回肠平滑肌组织中的MLCP活性,在用毒蕈碱激动剂卡巴胆碱进行药物处理后会有额外的磷酸化。电场刺激(EFS)从神经释放乙酰胆碱,增加了张力和RLC磷酸化,但没有增加MYPT1 T696或T853磷酸化。在小鼠中条件性敲除MYPT1或敲入突变T853A对离体回肠组织中EFS的频率-最大张力反应没有影响。回肠平滑肌中的生理性RLC磷酸化和张力发展取决于肌球蛋白轻链激酶和MLCP活性,而组成型MYPT1磷酸化没有变化。
由肌球蛋白调节轻链(RLC)磷酸化引发的平滑肌收缩取决于钙/钙调蛋白依赖性肌球蛋白轻链激酶(MLCK)和肌球蛋白轻链磷酸酶(MLCP)的相对活性。我们利用(1)平滑肌特异性敲除MYPT1;(2)含有T853A敲入突变的不可磷酸化MYPT1;以及(3)测量电场刺激引发的胆碱能神经刺激后的张力和蛋白质磷酸化反应,研究了成年小鼠回肠平滑肌中MLCP调节亚基MYPT1的生理作用。来自MYPT1(SM-/-)小鼠的离体MYPT1缺陷组织收缩和舒张迅速,对氯化钾和卡巴胆碱处理及洗脱的持续反应分别有适度差异。同样,对收缩过程中负责RLC磷酸化的调节蛋白的测量也显示出适度变化。正常小鼠与MYPT1 T853A敲入小鼠的组织对卡巴胆碱的收缩或RLC磷酸化反应没有差异。定量分析显示,在静息条件下野生型组织中存在大量的MYPT1 T696和T853磷酸化,预计MLCP磷酸酶受到高度抑制。MYPT1缺陷组织中PP1cδ活性降低可能类似于野生型组织中由于组成型磷酸化的MYPT1导致的MLCP活性减弱。电场刺激增加了野生型小鼠组织中的RLC磷酸化和张力发展,而MYPT1磷酸化没有增加。因此,回肠平滑肌中的生理性RLC磷酸化和张力发展似乎取决于MLCK和MLCP活性,而组成型MYPT1磷酸化没有变化。